Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
BMC Med Ethics ; 24(1): 72, 2023 09 21.
Article in English | MEDLINE | ID: mdl-37735670

ABSTRACT

BACKGROUND: Forward-looking, democratically oriented governance is needed to ensure that human genome editing serves rather than undercuts public values. Scientific, policy, and ethics communities have recognized this necessity but have demonstrated limited understanding of how to fulfill it. The field of bioethics has long attempted to grapple with the unintended consequences of emerging technologies, but too often such foresight has lacked adequate scientific grounding, overemphasized regulation to the exclusion of examining underlying values, and failed to adequately engage the public. METHODS: This research investigates the application of scenario planning, a tool developed in the high-stakes, uncertainty-ridden world of corporate strategy, for the equally high-stakes and uncertain world of the governance of emerging technologies. The scenario planning methodology is non-predictive, looking instead at a spread of plausible futures which diverge in their implications for different communities' needs, cares, and desires. RESULTS: In this article we share how the scenario development process can further understandings of the complex and dynamic systems which generate and shape new biomedical technologies and provide opportunities to re-examine and re-think questions of governance, ethics and values. We detail the results of a year-long scenario planning study that engaged experts from the biological sciences, bioethics, social sciences, law, policy, private industry, and civic organizations to articulate alternative futures of human genome editing. CONCLUSIONS: Through sharing and critiquing our methodological approach and results of this study, we advance understandings of anticipatory methods deployed in bioethics, demonstrating how this approach provides unique insights and helps to derive better research questions and policy strategies.


Subject(s)
Bioethics , Gene Editing , Humans , Social Sciences , Genome, Human , Policy
3.
J Responsible Innov ; 8(3): 382-420, 2021.
Article in English | MEDLINE | ID: mdl-35281674

ABSTRACT

The rapid development of human genome editing (HGE) techniques evokes an urgent need for forward-looking deliberation regarding the aims, processes, and governance of research. The framework of anticipatory governance (AG) may serve this need. This article reviews scholarly discourse about HGE through an AG lens, aiming to identify gaps in discussion and practice and suggest how AG efforts may fill them. Discourse on HGE has insufficiently reckoned with the institutional and systemic contexts, inputs, and implications of HGE work, to the detriment of its ability to prepare for a variety of possible futures and pursue socially desirable ones. More broadly framed and inclusive efforts in foresight and public engagement, focused not only upon the in-principle permissibility of HGE activities but upon the contexts of such work, may permit improved identification of public values relevant to HGE and of actions by which researchers, funders, policymakers, and publics may promote them.

4.
AMA J Ethics ; 21(12): E1071-1078, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31876472

ABSTRACT

Although women are inextricably involved in the study of germline editing, their interests have not been significantly represented in debates about the evolution of genome editing technology. Discussions have taken place about effects of germline editing on women as parents and members of families, but key discussions about women's health and well-being as patients and subjects are lacking. This neglect is due in part to restrictions on uterine transfer of modified human embryos, a boundary that has now been crossed. As a result, only scant discussion has taken place about safeguards needed to ensure that women who participate in germline modification research are not exposed to disproportionate risk in exchange for benefits they might expect for future offspring. This omission sets the stage for serious ethical implications for women and their families.


Subject(s)
Embryo Research/ethics , Gene Editing/ethics , Germ Cells , Women's Health , Biomedical Research , Female , Gene Editing/methods , Genome, Human/genetics , Humans , Women's Health/ethics
5.
7.
Cell Stem Cell ; 12(3): 285-91, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-23472870

ABSTRACT

The nature of compensation for women who donate eggs (oocytes) for research remains a contentious issue internationally. This position paper lays out the arguments for, and discusses the arrangements in which, a modest payment might be ethically justifiable.


Subject(s)
Oocytes , Stem Cell Research/ethics , Female , Humans , Tissue and Organ Procurement/ethics
10.
Cell Stem Cell ; 5(1): 27-30, 2009 Jul 02.
Article in English | MEDLINE | ID: mdl-19570511

ABSTRACT

This report considers whether research involving the creation of human-animal interspecies somatic cell nuclear transfer (iSCNT) embryos raises new ethical issues, and if so, whether it requires additional or special criteria and oversight distinct from research on human-animal chimeras.


Subject(s)
Nuclear Transfer Techniques/ethics , Biomedical Research/ethics , Blastocyst/cytology , Embryo Culture Techniques/ethics , Embryonic Development , Embryonic Stem Cells/cytology , Genetic Research/ethics , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...